Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccine

Immunological evaluation of personalized peptide vaccination in refractory small cell lung cancer

(2012) Yasuhiro Terazaki et al.   CANCER SCIENCE

Therapeutic Cancer Vaccines: Current Status and Moving Forward

(2012) J. Schlom   JNCI-Journal of the National Cancer Institute

Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study

(2011) Kazumasa Matsumoto et al.   BJU INTERNATIONAL

Assessment of immunological biomarkers in patients with advanced cancer treated by personalized peptide vaccination

(2011) Masanori Noguchi et al.   CANCER BIOLOGY & THERAPY

CpG or IFN-α are more potent adjuvants than GM-CSF to promote anti-tumor immunity following idiotype vaccine in multiple myeloma

(2011) Sungyoul Hong et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Phase II study of personalized peptide vaccination for castration-resistant prostate cancer patients who failed in docetaxel-based chemotherapy

(2011) Masanori Noguchi et al.   PROSTATE

Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion

(2011) R. D. Schreiber et al.   SCIENCE

A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancer

(2010) Masanori Noguchi et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Overcoming the hurdles of randomised clinical trials of therapeutic cancer vaccines

(2010) Tetsuro Sasada et al.   EUROPEAN JOURNAL OF CANCER

Phase I Trial of a Personalized Peptide Vaccine for Patients Positive for Human Leukocyte Antigen–A24 With Recurrent or Progressive Glioblastoma Multiforme

(2010) Mizuhiko Terasaki et al.   JOURNAL OF CLINICAL ONCOLOGY

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

(2010) Philip W. Kantoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Alphavirus Replicon Particles Expressing TRP-2 Provide Potent Therapeutic Effect on Melanoma through Activation of Humoral and Cellular Immunity

(2010) Francesca Avogadri et al.   PLoS One

A phase I study of personalized peptide vaccination using 14 kinds of vaccine in combination with low-dose estramustine in HLA-A24-positive patients with castration-resistant prostate cancer

(2010) Masanori Noguchi et al.   PROSTATE

Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients, a phase II trial

(2009) Ninke Leffers et al.   INTERNATIONAL JOURNAL OF CANCER

Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia

(2009) Gemma G. Kenter et al.   NEW ENGLAND JOURNAL OF MEDICINE